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Background: Toxocara canis is a nematode that parasitizes dogs, while humans are paratenic hosts. When humans
are infected the migrating larvae damage the liver, lungs and even the nervous system. Larva migrans diagnosis is
based on immunological techniques; however, the commercial immunodiagnostic kits detect anti-T. canis antibodies
which may cross-react with other parasites, mainly nematodes with extra-intestinal migration. Moreover, antibodies do
not necessarily reflect an active infection; so detection and quantification of circulating antigens may provide
appropriate and timely information for treatment, which prevents irreversible damage. Here we report the
standardization of a monoclonal antibody based antigen capture ELISA to diagnose human toxocariasis without
cross-reaction.
Methods: We developed anti-T. canis polyclonal antibodies in rabbits and a monoclonal antibody in mouse
which did not cross-react with 15 antigens from several parasites. The sandwich ELISA standardization was performed
using sera from mice experimentally infected. We tested the method using 29 positive and 58 negative human sera
previously typified with a commercial kit, which detects antibodies.
Results: Only 5.0 μg/mL and 10 μg/mL polyclonal antibodies and monoclonal antibody, respectively, were needed in
the sandwich ELISA standardization, detecting since 440 pg/mL larva antigens. Nine out of 29 antibody-positive sera
were also positive for antigens and no false positive were found. Taking the antibody kit as the reference standard, the
sensibility and specificity of the antigen test were 31% and 100%, respectively.
Conclusions: With these tools we established a detection threshold as low as 440 pg/mL antigen. Monoclonal antibody
is specific, and did not cross-react with antigens from other parasites. Detection of circulating antigens helps
provide appropriate and timely treatment and prevents irreversible damage.
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The migration of Toxocara canis larvae is injurious to hu-
man beings, because they invade the liver, the lungs or the
nervous system [1]. Dogs are definitive hosts, and the para-
site successfully infects puppies by uterine, trans-mammary
or environmental routes, with prevalence near 100% in
some places [2]. In contrast, 12-21% of adult dogs are in-
fected with the parasite [3]. As Toxocara females shed an
average of 68,000 eggs/day, dogs are an important source of
environmental contamination [4,5]. Children are most* Correspondence: macotelam@yahoo.com
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article, unless otherwise stated.susceptible to infection with Toxocara embryonated eggs
due to their playing behavior and their tendency to eat dirt.
Humans serve as paratenic hosts and the migrating parasite
produces: visceral larva migrans (VLM) characterized by
hepatic damage and Löffler syndrome with fever, pulmon-
ary inflammatory infiltrate and eosinophilia [6]; ocular
larva migrans (OLM) which in severe cases leads to eye-
sight loss [7]; eosinophilic meningo-encephalitis (EME) [8];
and covert toxocariasis (CT) [9]. Currently, larva migrans
is diagnosed by immunological methods, which detect anti-
bodies against excretion-secretion antigens [10]. However,
this method has limitations, i.e. there is cross-reactivity with
antigens from other parasites [10-12]. For treatment pur-
poses it is important to know if there are circulatingMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ture of T. canis larvae excretion and secretion antigens
(L2TES) as an alternative diagnostic strategy, but with vari-
able results [13-15]. Here, we report the standardization of
an ELISA to capture and quantify circulating Toxocara an-




Protocol was approved by the research and ethic commit-
tees of National Institute of Pediatrics. All animal proce-
dures were performed in accordance with the guidelines of
the Coordinator Commission of the National Institutes of
Health of Mexico (Institutos Nacionales de Salud, NOM-
062-ZOO-1999).
Toxocara canis larvae
T. canis adults were obtained from the small intestines
of puppies euthanized at the Canine Control Centre in
Tlalpan, México D.F., as described elsewhere [3]. Para-
site females were isolated with a paintbrush or forceps,
washed with PBS pH 7.2 and processed for culture in
the SGHP medium (Saline, Glucose, Human Plasma)
described previously [4]. Toxocara eggs were harvested,
concentrated by centrifugation, and incubated for one
month until larvae developed, which were induced to
hatch following the physiological method described else-
where [16]. Larvae were purified with Lymphoprep and
maintained in RPMI-1640 medium, to collect excretion-
secretion antigens (L2TES) in a tube containing protease
inhibitors cocktail (Sigma Aldrich, USA); subsequently
they were concentrated by centrifugation in Amicon col-
umns (10 KDa cutoff), quantified by the Bradford method,
aliquoted and stored at −70°C until use [17].
Monoclonal antibody (MoAb) production
Five female BALB/c mice were intraperitoneally inocu-
lated with 500 live Toxocara larvae. Every two weeks a
blood sample was collected from the tail vein; the sera
were used to evaluate the immune response. Thirty days
later, one mouse was euthanized, its spleen was isolated
and the cells were fused with the mouse myeloma line
X63Ag8.653 at a 5:1 ratio. Hybrid cells were selected
following the standard method [18]. Chimeric cells se-
creting antibodies against T. canis larvae were selected.
The cross-reactivity was tested using both excretion-
secretion and somatic antigens of T. canis adult. Also
Toxocara cati, Ascaris suum, Trichinella spiralis, Ancylos-
toma caninum, Dipylidium caninum, Fasciola hepatica,
Leishmania mexicana, Trypanosoma cruzi, Giardia intesti-
nalis, Trichomonas vaginalis and Acanthamoeba spp. anti-
gens were tested. The controls were hyperimmune and
preimmune sera from experimentally infected mouse. OneMoAb (termed INP-1E4G4C2) was selected and cloned
twice by limiting dilution [19]. The resultant antibody was
purified using Montage Antibody Purification Kit with Pro-
sep ®-G (Millipore, USA), typed [20] quantified and stored
at −20°C until use.Polyclonal antibodies (PoAb) production
Two New Zealand rabbits were intraperitoneally injected
with five thousand T. canis live larvae. To detect antibody
increase, blood samples were obtained from the ear vein
weekly. The rabbits were anesthetized and euthanized by
bleeding when the titer was1:64,000. Serum was harvested
and the IgG fraction was isolated with the Montage Anti-
body Purification Kit with Prosep ®-G (Millipore, USA),
following the manufacturer’s instructions. The protein
concentration was determined, and the antibodies were di-
vided into aliquots and stored at −20°C until use.Determination of the optimal MoAb concentration for
ELISA
ELISA plates Immulon 2HB (Dynatech, USA) was coated
with 100 μL/well of 0.0 to 40 μg/mL MoAb in borate
buffer and incubated overnight at 4°C. The plates were
then washed three times and non-specific binding sites
were blocked with 1% skimmed milk in PBS-Tween 20
(0.05%) for 30 min at 37°C and then rinsed with
0.9%NaCl −0.05%Tween 20. An anti-mouse IgG-HRP
conjugate (Sigma, A4416) was added at a 1:8,000 dilution
in PBS-Tween 20, incubated for 2 h at 37°C and washed
three times with 0.9%NaCl −0.05%Tween 20. The reaction
was revealed with chromogen/substrate solution (0.05 M
citrate/citric acid, 0.04 mg O-phenylenediamine and 0.12%
H2O2). The reaction was stopped with H2SO4 and the ab-
sorbance was measured at 490 nm on an automatic ELISA
reader Teca (Sunrise, Switzerland). The MoAb optimal
concentration for the ELISA was 10.0 μg/mL (Figure 1).Sandwich ELISA standardization for L2TES detection
The L2TES capture was performed as follows: polystyr-
ene wells were coated overnight at 4°C with 0.1, 1.0, 5.0,
10.0 and 25 μg/mL of PoAb in borate buffer (100 mM
boric acid, 0.025 M sodium tetraborate, 75 mM, sodium
chloride) pH 8. Unspecific sites were blocked for one
hour at room temperature with 1% skimmed milk in
PBS-Tween 20. L2TES were added at 0.0, and tenfold in-
crement from 0.0001, until 10 μg/mL and incubated at
37°C for 2 h. Afterwards 10 μg/mL of the MoAb were
added and incubated at room temperature. The anti-
mouse IgG-HRP (1:8,000) was aggregated and incubated
as described before. In every step, the plate was washed
three times with NaCl -Tween 20.
Figure 1 Determination of the optimal 1E4G4C2 MoAb concentration
for the ELISA. 96-well polystyrene plate was coated with 0.0, 1.0, 2.5, 5.0,
10, 20 and 40 μg/mL of MoAb; non-specific binding sites were blocked
with 1% skimmed milk; anti-mouse IgG-HRP conjugate was added at a
1:8,000 dilution and the reaction was revealed with chromogen/substrate
solution. The results are shown as the arithmetic media ± standard
deviation from three triplicate assays.
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We tested the method using 29 positive and 58 negative
serum samples previously tested with a commercial kit
(Sciemedx, USA) which detects antibodies against T. canis
larvae antigens. A fraction of each sample was treated with
EDTA to dissociate immune complexes; briefly, samples
were diluted 1:1 with 1.0 M EDTA, pH 7.5, boiled for
10 minutes and centrifuged at 12,000 x g/5 minutes, and
the supernatant was used in the test [21]. Another serum
fraction was used diluted with PBS instead of EDTA.Table 1 Detection of cross-reactions of INP-1E4G4C2 MoAb ag
Absorbance at 490 nm
Antigens INP-1E4G4C2 MoAb
Toxocara canis L2TES 2.5
Toxocara canis larvae somatic antigen 2.5
Toxocara canis ATES 0.27












Cut-off: 0.35; L2TES: Larvae 2 Toxocara excretion-secretion antigens. ATES: SecretionELISA was performed with the PoAb at 5 μg/mL, 100 μL
of sera with or without treatment with EDTA, the MoAb
at 10 μg/mL and anti-mouse IgG-HRP diluted 1:8,000.
In all cases, the cut-off value was obtained adding
three times the standard deviation to the mean absorb-
ance value of the negative samples. The experiments
were repeated three times.
Western blot
Electrophoresis was performed in a Mini-Protean II
(BioRad, USA) on 4-20% polyacrylamide slab gradient
gels (BioRad,USA), with Kaleidoscope prestained standards
(BioRad,USA) and 100 μg L2TES/well; electrophoresis was
at 150 V for 2 h. Proteins were transferred to a PVDF mem-
brane Immobilon (Millipore, USA) at 60 V for 1.5 h in Mini
Trans-Blot (BioRad, USA). Nonspecific sites were blocked
overnight with 5% skimmed milk in PBS-Tween 20 at
4°C. The blot was then incubated 2 h with INP-
1E4G4C2 MoAb at room temperature and washed with
PBS-Tween 20 (0.05%). The anti-mouse IgG-HRP con-
jugate, diluted 1:1,000 was then added and incubated
for 2 h at room temperature. After three washes with
PBS-Tween 20 (0.05%) and two with PBS, the substrate/
chromogen solution (30 mg 3,3`-Diaminobenzidine, and
6 μL 30% H2O2 in 60 mL PBS) was added and the reaction
was stopped with distilled water.
Results
The INP-1E4G4C2 is an IgG1 isotype MoAb that did
not show cross-reactivity with other parasite antigens
tested, including somatic antigens from T. canis adults.ainst antigens from several parasites
















excretion antigens from Toxocara canis adult.
Figure 2 Determination PoAb optimal concentration to L2TES capture.
96-well polystyrene plate was coated with several concentrations
of PoAb, non-specific binding sites were blocked with 1% skimmed
milk; added different concentrations; 10 μg/mL of INP-1E4G4C2 MoAb,
anti-mouse IgG-HRP conjugate at a 1:8,000 dilution and the reaction was
revealed with chromogen/substrate solution. The reaction was stopped
with H2SO4 and the absorbance was measured at 490 nm. The results
are shown as the arithmetic media ± standard deviation from three
triplicate assays.
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ance values; in contrast, the hyperimmune mouse serum
recognized several parasites (Table 1). MoAb optimal con-
centration was 10 μg/mL because the absorbance inflec-
tion point was at 5.0 μg/mL (Figure 1). Sandwich ELISA
standardization was with 5.0 μg/mL and 10 μg/mL of theFigure 3 Detection of L2TES in human sera. 96-well polystyrene plate
was coated with PoAb at 5 μg/mL, sera previously treatment with
EDTA 100 μL, the MoAb at 10 μg/mL and anti-mouse IgG-HRP diluted
1:8,000.The reaction was revealed with chromogen/substrate solution.
The reaction was stopped with H2SO4 and the absorbance was
measured at 490 nm. The results are shown as the arithmetic media ±
standard deviation from three triplicate assays.polyclonal and monoclonal antibodies, and was detected
since 440 pg/mL of L2TES (Figure 2).
With this technique we found from 470 pg/mL to 10 ng/
mL of antigen in 9 out of 29 (sensitivity = 31%) positive sera
previously diagnosed with a commercial kit that detects
antibodies. In none of the 58 negative samples the antigen
was detected (specificity = 100%) (Figure 3). We were able
to detect antigens only in samples treated with EDTA.
The western blot revealed that INP-1E4G4C2 MoAb
recognized three bands of 130, 205 and >205 KDa, re-
spectively (Figure 4).
Discussion
Toxocara larva migrans diagnosis is not easy, because the
methods are based on the detection of antibodies against
the parasite, which do not determine the infection status
and may give rise to false positive results, due to cross-
reactions with other parasites, especially nematodes.
With the intention to develop a technique for L2T.canis
circulating antigens detection, we obtained one mono-
clonal antibody against L2T. canis antigens; which nei-
ther identified T. canis adult excretion-secretion and
somatic antigens, nor presented cross-reactivity with
other nematodes such as: T. cati, A. suum, A. caninum
or T. spiralis (Table 1).Figure 4 Western blot of L2TES with INP-1E4G4C2 MoAb Electrophoresis
was performed on 4–20% polyacrylamide slab gradient gels former
and separated at 150 V for 2 h. Proteins were transferred to a PVDF
membrane immobilon. Nonspecific sites were blocked overnight with
5% skimmed milk in PBS-tween 20 at 4°C, incubated 2 h with
INP-1E4G4C2 MoAb at room temperature and washed three times.
Added and incubated for 2 h at room temperature with anti-mouse
IgG-HRP conjugate (diluted 1:1,000) and washed three times; the
substrate/chromogen solution was added and the reaction was
stopped with distilled water. (M) kaleidoscope prestained standards. (1)
100 μg L2TES/well.
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antibodies instead of monoclonal, which gave higher
analytical sensitivity (440 pg/mL of L2TES) than those
described by Yokoi and Ishiyama, who used MoAbs to
coat the plate and were able to capture antigen from
4.0 ng/mL and 5.0 ng/mL, respectively [14,15].
It has been suggested that several monoclonal antibodies
can detect more than one band and that recognize more
than one epitope [15]. The INP-1E4G4C2 MoAb detected
three bands of L2TES, perhaps the capture of pg/mL quan-
tities of L2TES was possible because the MoAb recognized
several proteins which share epitopes. Yokoi [14] obtained
a monoclonal antibody (IgG1) that did not cross-react with
three parasites analyzed (A. suum, D. immitis and T. canis
adult). Another study reported two monoclonal antibodies:
one (IgM) that only identified T. canis excretion-secretion
antigens, and other (IgG1) that distinguish T. canis and T.
cati excretion-secretion antigens [13].
When we tested the method using antibody-positive
samples, as defined by a commercial kit, we found circu-
lating antigens in 31.0% of serum samples and none
among 58 negative samples. These data suggest that 9
children had circulating antigens and perhaps larvae mi-
gration. It is likely that another 20 cases had antibodies
against Toxocara from past infections, although it can-
not be ruled out that they were individuals harboring
other parasites, because the ELISA kit is unable to dis-
tinguish past infections from active infection and gives
cross-reactions. Based on these data, we believe that the
INP-1E4G4C2 MoAb could serve as a useful tool to
demonstrate the presence of L2T.canis circulating anti-
gens, and therefore, to establish the infection status of
the host. Moreover, we considered it is necessary to test
the sandwich ELISA in more samples from patients.
Conclusions
With these tools we established a detection threshold as
low as 440 pg/mL antigen. Monoclonal antibody is spe-
cific, and did not cross-react with antigens from other
parasites. Detection of circulating antigens helps provide
appropriate and timely treatment and prevents irrevers-
ible damage.
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